Published in Curr Opin Cardiol on March 01, 2007
Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol (2010) 1.95
Cellular magnetic resonance imaging: potential for use in assessing aspects of cardiovascular disease. Cytotherapy (2008) 0.78
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol (2006) 3.20
Gene dosage of the common variant 9p21 predicts severity of coronary artery disease. J Am Coll Cardiol (2010) 3.07
Bivalirudin for primary percutaneous coronary interventions: outcome assessment in the Ottawa STEMI registry. Circ Cardiovasc Interv (2012) 2.07
The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care. Can J Cardiol (2011) 1.78
Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Can J Cardiol (2007) 1.70
Can differences in corrected coronary opacification measured with computed tomography predict resting coronary artery flow? J Am Coll Cardiol (2011) 1.70
18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial. J Nucl Med (2010) 1.56
The effects of continuous positive airway pressure on myocardial energetics in patients with heart failure and obstructive sleep apnea. J Am Coll Cardiol (2007) 1.53
Effect of bisoprolol on right ventricular function and brain natriuretic peptide in patients with heart failure. Congest Heart Fail (2004) 1.51
Frequency of peripartum cardiomyopathy. Am J Cardiol (2006) 1.46
The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure. Can J Cardiol (2012) 1.44
Benefit of Neoral C2 monitoring in de novo cardiac transplant recipients receiving basiliximab induction. Transplantation (2008) 1.44
Effects of ACE inhibitors on cardiac angiotensin II and aldosterone in humans: "Relevance of lipophilicity and affinity for ACE". Am J Hypertens (2010) 1.43
Acute reversible left ventricular dysfunction secondary to alcohol. Can J Cardiol (2007) 1.42
The prevalence of cardiac risk factors in women 45 years of age or younger undergoing angiography for evaluation of undiagnosed chest pain. Can J Cardiol (2002) 1.40
Does FDG PET-assisted management of patients with left ventricular dysfunction improve quality of life? A substudy of the PARR-2 trial. Can J Cardiol (2011) 1.37
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies. Can J Cardiol (2008) 1.15
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol (2009) 1.04
Management of acute severe perioperative failure of cardiac allografts: a single-centre experience with a review of the literature. Can J Cardiol (2007) 0.97
Relationship between natriuretic peptides and inflammation: proteomic evidence obtained during acute cellular cardiac allograft rejection in humans. J Heart Lung Transplant (2008) 0.95
X-ray-induced photo-chemistry and X-ray absorption spectroscopy of biological samples. J Synchrotron Radiat (2012) 0.93
Usefulness of beta-blocker therapy and outcomes in patients with pulmonary arterial hypertension. Am J Cardiol (2012) 0.91
Tricuspid valve chordal tissue in endomyocardial biopsy specimens of patients with significant tricuspid regurgitation. J Heart Lung Transplant (2005) 0.91
Primary percutaneous coronary angioplasty with and without eptifibatide in ST-segment elevation myocardial infarction: a safety and efficacy study of integrilin-facilitated versus primary percutaneous coronary intervention in ST-segment elevation myocardial infarction (ASSIST). Circ Cardiovasc Interv (2009) 0.90
2001 Canadian Cardiovascular Society Consensus Conference on cardiac transplantation. Can J Cardiol (2003) 0.90
Physician specialty and quality of care for CHF: different patients or different patterns of practice? Can J Cardiol (2003) 0.90
BNP-guided therapy not better than expert's clinical assessment for beta-blocker titration in patients with heart failure. Congest Heart Fail (2005) 0.87
Effect of Orlistat in obese patients with heart failure: a pilot study. Congest Heart Fail (2005) 0.87
Acute and chronic effects of continuous positive airway pressure therapy on left ventricular systolic and diastolic function in patients with obstructive sleep apnea and congestive heart failure. Can J Cardiol (2008) 0.87
Worsening renal function and prognosis in pulmonary hypertension patients hospitalized for right heart failure. Congest Heart Fail (2012) 0.87
Cardiac allograft vasculopathy: pathology, prevention and treatment. Curr Opin Cardiol (2006) 0.85
Imaging the failing right ventricle. Curr Opin Cardiol (2012) 0.85
Pharmacokinetics in stable heart transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations. J Heart Lung Transplant (2011) 0.84
Depression in heart failure. Curr Opin Cardiol (2013) 0.84
The concept of ventricular reserve in heart failure and pulmonary hypertension: an old metric that brings us one step closer in our quest for prediction. Curr Opin Cardiol (2011) 0.84
Atrial natriuretic peptides in heart failure: pathophysiological significance, diagnostic and prognostic value. Can J Physiol Pharmacol (2011) 0.84
Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm. Can J Cardiol (2004) 0.84
Reduction of cyclosporine following the introduction of everolimus in maintenance heart transplant recipients: a pilot study. Transpl Int (2010) 0.83
Mechanisms of functional mitral regurgitation in ischemic cardiomyopathy determined by transesophageal echocardiography (from the Surgical Treatment for Ischemic Heart Failure Trial). Am J Cardiol (2013) 0.83
Prolonged basiliximab use as an alternative to calcineurin inhibition to allow renal recovery late after heart transplantation. J Heart Lung Transplant (2008) 0.83
Relation between right ventricular function and increased right ventricular [18F]fluorodeoxyglucose accumulation in patients with heart failure. Circ Cardiovasc Imaging (2010) 0.83
Neuroendocrine profiling of humans receiving cardiac allografts. J Heart Lung Transplant (2005) 0.83
Under-utilization of mechanical circulatory support in Canada: why and what can be done? Artif Organs (2004) 0.81
Usefulness of computed tomographic coronary angiography in patients with acute chest pain with and without high-risk features. Am J Cardiol (2010) 0.81
Enhanced external counterpulsation in ischemic heart disease and congestive heart failure. CMAJ (2004) 0.81
Sleep apnea in chronic heart failure. Curr Opin Cardiol (2008) 0.81
Recent progress in the genetics of cardiomyopathy and its role in the clinical evaluation of patients with cardiomyopathy. Curr Opin Cardiol (2011) 0.80
Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial. Trials (2013) 0.80
The role of vitamin D in chronic heart failure. Curr Opin Cardiol (2013) 0.80
Persistent orthopnea and the prognosis of patients in the heart failure clinic. Congest Heart Fail (2004) 0.80
Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial. Cerebrovasc Dis (2013) 0.80
Do high doses of AT(1)-receptor blockers attenuate central sympathetic outflow in humans with chronic heart failure? Clin Sci (Lond) (2013) 0.80
Diagnosis of graft coronary artery disease. Curr Opin Cardiol (2007) 0.79
Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus. Transplantation (2006) 0.79
Is ventilatory efficiency (VE/VCO(2) slope) associated with right ventricular oxidative metabolism in patients with congestive heart failure? Eur J Heart Fail (2008) 0.79
Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion. J Heart Lung Transplant (2005) 0.79
Acute myocardial infarction and anorexia nervosa. Int J Eat Disord (2010) 0.78
Cyclosporine reduction in the presence of everolimus: 3-month data from a Canadian pilot study of maintenance cardiac allograft recipients. J Heart Lung Transplant (2008) 0.78
An unusual case of hypertensive diastolic heart failure with bilateral subclavian artery stenosis. Can J Cardiol (2009) 0.78
Heart transplantation at the Ottawa heart institute: comparison with Canadian and international results. Artif Organs (2004) 0.78
New therapies in acute decompensated heart failure. Curr Opin Cardiol (2008) 0.77
Cardiorenal syndrome and heart failure. Curr Opin Cardiol (2010) 0.77
Thyrotoxicosis-an uncommon cause of heart failure. Cardiovasc Pathol (2005) 0.77
Images in cardiovascular medicine. Fluorine-18-labeled deoxyglucose positron emission tomography in the diagnosis and management of aortitis with pulmonary artery involvement. Circulation (2005) 0.77
Ventricular assist devices as a bridge to cardiac transplantation: the Ottawa experience. Artif Organs (2004) 0.77
Reperfusion times for ST elevation myocardial infarction: a prospective audit. Mcgill J Med (2007) 0.77
Prevalence and clinical implications of anemia in congestive heart failure patients followed at a specialized heart function clinic. Congest Heart Fail (2006) 0.77
Ultrafiltration in the management of acute decompensated heart failure. Curr Opin Cardiol (2010) 0.76
Right and left ventricular uptake with Rb-82 PET myocardial perfusion imaging: markers of left main or 3 vessel disease. J Nucl Cardiol (2009) 0.76
Cardiac signaling molecules and plasma biomarkers after cardiac transplantation: impact of tacrolimus versus cyclosporine. J Heart Lung Transplant (2013) 0.76
Cardiac retransplantation: an ethical dilemma. Curr Opin Cardiol (2006) 0.76
A randomised study for optimising crossover from ticagrelor to clopidogrel in patients with acute coronary syndrome. The CAPITAL OPTI-CROSS Study. Thromb Haemost (2016) 0.76
In vivo evaluation of the biocompatibility of the totally implantable ventricular assist device (HeartSaver VAD). ASAIO J (2003) 0.76
Preserved Estimated Ejection Fraction in a Patient With Takotsubo Cardiomyopathy Due to Good News. Can J Cardiol (2015) 0.75
Cardiac transplantation in HIV-positive patients: are we there yet? J Heart Lung Transplant (2007) 0.75
Response to letter regarding article, "Bivalirudin for primary percutaneous coronary interventions: outcome assessment in the Ottawa STEMI registry". Circ Cardiovasc Interv (2013) 0.75
Heart failure and sleep-disordered breathing. Curr Opin Cardiol (2016) 0.75
Computed tomographic coronary angiography for patients with heart failure (CTA-HF): a randomized controlled trial (IMAGE HF Project 1-C). Trials (2013) 0.75
Use of calcium channel blockers and angiotensin-converting enzyme inhibitors after cardiac transplantation. Curr Opin Cardiol (2007) 0.75
Improved early survival with the total artificial heart. Artif Organs (2004) 0.75
Genetic testing in cardiomyopathies: an update on indications and benefits. Curr Opin Cardiol (2016) 0.75
The impact of obesity on heart failure. Curr Opin Cardiol (2017) 0.75
Canadian Consensus on cardiac transplantation in pediatric and adult congenital heart disease patients 2004: executive summary. Can J Cardiol (2005) 0.75
Canadian Physician Attitudes and Practices Regarding Periprocedural Management of Oral Anticoagulation for Cardiac Catheterization. Can J Cardiol (2017) 0.75
Unprotected left main coronary artery stenting with zotarolimus (Endeavor) drug-eluting stents: a single center retrospective experience. Catheter Cardiovasc Interv (2012) 0.75
Thermal therapy: a viable adjunct in the treatment of heart failure? Congest Heart Fail (2008) 0.75
The acutely occluded left main coronary artery culprit in cardiogenic shock and initial percutaneous coronary intervention: a substudy of the Manitoba "no option" left main PCI registry. Can J Physiol Pharmacol (2012) 0.75
An update in the management of acute decompensated heart failure. Curr Opin Cardiol (2014) 0.75
Three year clinical outcomes with zotarolimus (Endeavor) drug-eluting stents in an unrestricted contemporary practice. Int J Cardiol (2013) 0.75
[B-type natriuretic peptide and cardiovascular disease]. Arq Bras Cardiol (2003) 0.75
The role of statins in chronic heart failure. Curr Opin Cardiol (2009) 0.75
RACER renal stents for large diameter left main coronary artery intervention. Int J Cardiol (2011) 0.75
Safety of coronary stenting with eptifibatide and ultra-low-dose heparin. Am J Cardiol (2005) 0.75
Heart rate and heart failure. Curr Opin Cardiol (2016) 0.75
Chemotherapy-related cardiac dysfunction: grey area in type I and type II classification. Curr Opin Cardiol (2016) 0.75
Posterior his bundle electrogram location in a patient with atrioventricular nodal reentrant tachycardia and structurally normal heart. Can J Cardiol (2011) 0.75
Infective endocarditis presenting as ST-elevation myocardial infarction: an angiographic diagnosis. Can J Cardiol (2012) 0.75